
VRTS
USDVirtus Investment Partners Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$164.310
Максимум
$165.075
Минимум
$160.455
Объем
0.06M
Фундаментальные показатели компании
Рыночная капитализация
1.1B
Отрасль
Asset Management
Страна
United States
Статистические данные торговли
Средний объем
0.08M
Биржа
NYQ
Валюта
USD
52-недельный диапазон
Отчет об анализе ИИ
Последнее обновление: 10 нояб. 2025 г.Virtus Investment Partners (VRTS) - Key Takeaways & Action Plan
Key Takeaway: Virtus Investment Partners (VRTS) is currently trading at $163.16, sitting just above a critical support level of $161.54. The stock has been under pressure, with a 52-week low of $142.18 and a 52-week high of $252.82. The recent decline is attributed to a combination of factors, including a negative revenue growth of -4.7% and a debt-to-equity ratio of 47.40, which is significantly above the industry average. The company is also facing challenges with negative cash flow and a low P/E ratio of 5.42, indicating that the market is pricing in significant headwinds.
Action Plan:
-
Immediate Action: If you're holding VRTS, consider reducing exposure or taking profits if the stock drops below $161.54, as this level has been a strong support in the past. The risk-reward is skewed to the downside in the near term.
-
Entry Strategy: If you're looking to enter, wait for a clear break above $165.00 with strong volume confirmation. This would indicate that the stock has found a new support level and could be a good entry point for a short-term trade.
-
Risk Management: Given the high debt levels and negative revenue growth, it's crucial to set a tight stop-loss at $153.95 to protect your capital. The stock is highly sensitive to market sentiment, and any negative news could trigger a sharp decline.
-
Long-term Outlook: The company is facing significant headwinds, and the stock is not suitable for long-term holding unless there's a clear turnaround plan. The negative cash flow and high debt levels are red flags that could lead to further downside pressure.
Bottom Line: VRTS is a high-risk, low-reward play right now. The stock is not suitable for long-term holding unless you're a short-term trader looking to capitalize on volatility. If you're holding it, consider reducing exposure and waiting for a clear trend reversal before making any new investments.
Bottom Line: Sell or avoid until the company addresses its debt issues and shows signs of revenue growth. The risk-reward is skewed to the downside in the near term.
This analysis is for informational purposes only and is not financial advice. Please consult with a financial advisor before making any investment decisions.
Связанные новости
Virtus Total Return Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice
Virtus Total Return Fund Inc. (NYSE:ZTR) previously announced the following monthly distribution on August 27, 2025: Ticker Amount of Distribution Ex-Date/Record Date Payable
Virtus Artificial Intelligence & Technology Opportunities Fund Discloses Sources of Distribution – Section 19(a) Notice
Virtus Artificial Intelligence & Technology Opportunities Fund (NYSE:AIO) previously announced the following monthly distribution on August 27, 2025: Ticker Amount of Distribution Ex-Date/Record
Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice
Virtus Diversified Income & Convertible Fund (NYSE:ACV) previously announced the following monthly distribution on August 27, 2025: Ticker Amount of Distribution Ex-Date/Record Date Payable
Morgan Stanley Maintains Underweight on Virtus Inv, Raises Price Target to $173
Morgan Stanley analyst Michael Cyprys maintains Virtus Inv with a Underweight and raises the price target from $170 to $173.
TD Cowen Maintains Hold on Virtus Inv, Lowers Price Target to $180
TD Cowen analyst Bill Katz maintains Virtus Inv with a Hold and lowers the price target from $196 to $180.
Virtus Investment Partners Announces Financial Results for Third Quarter 2025
Earnings Per Share - Diluted of $4.65; Earnings Per Share - Diluted, as Adjusted, of $6.69 Total Sales of $6.3B; Net Flows of ($3.9B); Assets Under Management of $169.3B Virtus Investment Partners, Inc.
Morgan Stanley Maintains Underweight on Virtus Inv, Lowers Price Target to $170
Morgan Stanley analyst Michael Cyprys maintains Virtus Inv with a Underweight and lowers the price target from $180 to $170.
Прогноз ИИBeta
Рекомендация ИИ
Обновлено в: 10 нояб. 2025 г., 16:05
64.6% Уверенность
Риск и торговля
Точка входа
$160.71
Взять прибыль
$166.40
Остановить убытки
$153.95
Ключевые факторы
Связанные акции
RCEL
Avita Medical Inc.
SIGIP
Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B
NLY
Annaly Capital Management Inc.
ADIL
Adial Pharmaceuticals Inc
CAPR
Capricor Therapeutics Inc.
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.